virus
bacteria
contribut
pathogenesi
natur
histori
childhood
respiratori
syncyti
viru
rsv
predomin
infant
toddler
human
rhinoviru
hrv
influenza
flu
virus
parainfluenza
viru
piv
adenoviru
adv
coronaviru
cov
human
enteroviru
hev
preval
older
common
children
asthma
develop
respiratori
symptom
especi
winter
mani
clinic
find
howev
result
respiratori
infect
requir
support
care
minim
exposur
respiratori
prevail
practic
nevertheless
escal
use
shortact
saba
longact
laba
inhal
corticosteroid
icss
leukotrien
receptor
antagonist
medic
expens
may
impos
seriou
advers
event
especi
young
therefor
identifi
control
trigger
asthma
deserv
studi
studi
unit
arab
emir
uae
surround
countri
evalu
respiratori
infect
nasopharyng
isol
patient
asthma
howev
studi
address
respiratori
viral
infect
commun
level
exampl
saudi
arabia
case
rsv
occur
novemb
march
case
report
month
kuwait
studi
investig
caus
agent
patient
lower
respiratori
tract
infect
use
pcr
reveal
rsv
hrv
major
isol
among
hospit
children
octob
march
human
cov
detect
patient
regular
surveil
especi
winter
necessari
pathogen
identifi
view
possibl
prevent
prospect
pilot
studi
aim
estim
preval
nasopharyng
isol
children
asthma
winter
season
identifi
clinic
impact
respiratori
symptom
function
main
object
address
import
control
respiratori
pathogen
treatment
childhood
asthma
multipl
week
apart
nasopharyng
specimen
collect
patient
decemb
march
tabl
control
particip
sampl
collect
januari
march
tabl
specimen
store
analysi
perform
use
respiratori
full
panel
assay
seegen
biotechnolog
inc
seoul
korea
instruct
assay
compos
four
panel
util
multiplex
onestep
realtim
pcr
identifi
virus
three
influenza
subtyp
seven
bacteria
virus
influenza
flu
b
piv
rsv
b
adv
hev
human
metapneumoviru
mpv
human
bocaviru
hbov
hrv
cov
cov
cov
bacteria
streptococcu
pneumonia
sp
haemophilu
influenza
hi
mycoplasma
pneumonia
chlamydophila
pneumonia
legionella
pneumophila
bordetella
pertussi
bp
bordetella
parapertussi
bpp
data
analyz
spss
statist
packag
version
descript
statist
includ
number
percentag
measur
valu
observ
variabl
appropri
anova
use
compar
zscore
one
hand
number
isol
pathogen
gina
asthma
control
score
ccq
score
hand
unpair
ttest
use
compar
zscore
children
asthma
control
test
statist
signific
defin
pvalu
fifti
nasopharyng
specimen
collect
decemb
march
patient
asthma
age
year
patient
recruit
studi
februari
tabl
data
avail
prior
time
later
result
includ
tabl
result
studi
perform
decemb
januari
shown
tabl
januari
februari
tabl
march
tabl
patient
respons
global
asthma
network
questionnair
shown
tabl
patient
use
daili
asthma
prophylaxi
tabl
addit
nasopharyng
specimen
also
collect
control
children
histori
asthma
age
year
result
shown
tabl
preval
isol
patient
control
shown
figur
common
organ
sp
hi
hrv
group
patient
decemb
thirtythre
pathogen
bacteria
virus
differ
type
isol
patient
asthma
patient
detect
isol
tabl
organ
sp
patient
hi
patient
bpp
patient
rhinoviru
patient
cov
patient
hev
patient
adv
patient
patient
four
patient
pathogen
pathogen
pathogen
pathogen
none
six
patient
rhinoviru
treatment
modif
start
ic
patient
increas
ic
dose
patient
ad
montelukast
salmeterol
ic
patient
tabl
nine
patient
mild
common
cold
symptom
ccq
score
rang
maximum
score
moder
symptom
ccq
score
rang
symptom
ccq
score
tabl
isol
patient
ccq
score
includ
sp
patient
hi
patient
bpp
patient
hrv
patient
twelv
patient
gina
assess
asthma
control
score
maximum
score
tabl
zscore
airway
resist
significantli
differ
compar
among
children
differ
number
pathogen
isol
anova
similarli
zscore
significantli
differ
among
children
differ
ccq
score
anova
gina
control
score
anova
patient
isol
profil
chang
major
patient
tabl
exampl
patient
acquir
bp
patient
rhinoviru
tabl
mani
previous
detect
virus
present
subsequ
test
eg
patient
lost
colon
cov
tabl
differ
strain
piv
also
appear
march
patient
patient
tabl
strain
detect
patient
tabl
worth
note
bp
bpp
detect
entir
studi
period
patient
bp
patient
tabl
increas
ic
dose
tabl
show
pathogen
isol
patient
sort
vari
degre
ccq
gina
assess
asthma
control
score
patient
ccq
score
gina
assess
asthma
control
score
increas
airway
resist
high
mean
zscore
suggest
poor
asthma
control
howev
patient
treatment
escal
impact
common
cold
symptom
airway
resist
shown
figur
patient
ccq
score
significantli
higher
zscore
nine
patient
wheez
disturb
sleep
per
week
tabl
six
patient
rhinoviru
cov
sever
atopi
patient
tabl
treatment
modif
treatment
modif
base
clinic
find
made
discret
pediatr
pulmonologist
detail
tabl
mani
patient
alreadi
control
medic
prior
studi
shown
tabl
control
decemb
twentythre
pathogen
isol
control
children
sp
children
hi
children
rhinoviru
children
flu
children
enteroviru
children
hbov
children
child
adv
child
tabl
figur
two
children
pathogen
pathogen
pathogen
pathogen
result
airway
resist
ccq
score
detail
tabl
zscore
airway
resist
significantli
differ
children
asthma
control
unpair
ttest
nasopharynx
reservoir
pathogen
associ
respiratori
diseas
asthma
airway
microbiom
studi
shown
bacteria
may
play
substanti
role
onset
evolut
sever
studi
conduct
test
hypothesi
nasopharyng
colon
communityacquir
pathogen
advers
impact
natur
histori
asthma
young
children
result
show
major
patient
asthma
sever
viral
pathogen
contribut
symptom
airway
resist
tabl
clinic
impact
respiratori
pathogen
asthma
control
shown
tabl
patient
increas
ccq
score
associ
colon
hi
bp
second
sampl
increas
airway
resist
patient
second
sampl
collect
could
due
colon
hi
advers
event
prior
adv
similarli
increas
airway
resist
patient
could
due
prior
cov
high
airway
resist
patient
could
due
cours
sever
asthma
also
relat
role
mani
environment
factor
air
pollut
humid
smoke
medic
adher
poor
inhal
techniqu
total
unexpect
role
respiratori
pathogen
consid
isol
sole
respons
asthma
control
respect
control
tabl
children
high
airway
resist
associ
multipl
colon
child
found
subsequ
symptom
allerg
rhiniti
mild
night
cough
patient
found
pertussi
increas
symptom
possibl
fals
attribut
worsen
asthma
control
lead
inappropri
escal
medic
infect
diagnos
tabl
addit
patient
asthma
increas
risk
pertussi
infect
highlight
pertussi
outbreak
mn
usa
popul
attribut
risk
percentag
asthma
risk
pertussi
calcul
consist
humor
immunoreact
bp
could
suppress
patient
therefor
target
patient
asthma
pertussi
surveil
vaccin
select
highrisk
group
might
appropri
strategi
children
asthma
may
increas
risk
might
facilit
use
ic
medic
also
inhibit
mucos
immun
respons
thu
encourag
colon
children
common
cold
symptom
asthma
prophylaxi
therapi
escal
associ
elev
gina
assess
asthma
control
score
increas
airway
resist
probabl
justifi
tabl
mild
common
cold
symptom
asthma
prophylaxi
therapi
increas
associ
increas
airway
resist
although
low
gina
assess
asthma
control
score
sever
common
cold
symptom
asthma
prophylaxi
therapi
escal
regardless
gina
assess
asthma
control
score
without
increas
airway
resist
probabl
intensif
trigger
sever
cold
symptom
instead
asthma
score
airway
resist
probabl
justifi
tabl
northern
hemispher
asthmarel
emerg
depart
visit
higher
septemb
month
late
fall
often
second
wave
fluctuat
throughout
winter
probabl
coincid
rhinoviru
symptomat
rhinoviru
infect
found
import
contributor
asthma
exacerb
studi
rhinoviru
hrv
detect
major
patient
figur
futur
studi
need
address
import
variabl
relev
organ
serotyp
especi
upper
vs
lower
respiratori
colon
host
suscept
eg
variabl
express
intercellular
adhes
airway
inflamm
report
infect
flu
virus
well
known
induc
sever
exacerb
pneumonia
c
pneumonia
hand
seem
involv
asthma
atyp
bacteria
c
pneumonia
pneumonia
detect
studi
popul
pathogen
may
import
adult
chronic
asthma
similarli
rsv
mpv
detect
patient
find
could
due
small
sampl
size
studi
region
epidem
pattern
pathogen
thu
surveil
cover
entir
year
necessari
studi
children
month
year
age
asthma
exacerb
high
preval
respiratori
pathogen
includ
rsv
hrv
pneumonia
c
pneumonia
hospit
associ
season
hrv
mpv
hbov
previous
report
children
asthma
current
studi
hbov
detect
healthi
child
tabl
mpv
patient
tabl
worth
note
zscore
patient
ccq
score
similar
ccq
score
figur
addit
zscore
correl
best
gina
assess
asthma
control
score
patient
ccq
score
r
figur
find
reflect
limit
use
fot
patient
signific
upper
respiratori
symptom
shown
influenc
fot
resist
measur
studi
find
support
need
strategi
limit
children
exposur
respiratori
virus
bacteria
especi
poorli
control
diseas
specif
measur
suggest
minim
recurr
infect
children
asthma
includ
hand
hygien
healthi
balanc
diet
activ
probiot
supplement
immunostimul
studi
howev
need
investig
whether
reduc
exposur
pathogen
would
improv
asthma
control
addit
role
environment
factor
air
pollut
humid
smoke
medic
adher
poor
inhal
techniqu
taken
consider
futur
studi
major
patient
asthma
viral
bacteri
pathogen
contribut
diseas
regular
surveil
could
play
role
asthma
care
especi
poorli
control
diseas
effect
strategi
minim
exposur
respiratori
pathogen
hand
hygien
incorpor
childhood
asthma
guidelin
approach
would
emphas
import
environment
control
measur
rather
reli
sole
escal
asthma
drug
therapi
potenti
toxic
studi
need
evalu
whether
strategi
minim
children
exposur
pathogen
would
improv
asthma
control
